Approaches to Treatment-2021-Winter-QTR-Term-wks-1-thru-11-
(11/29/2021-02/13/2022)-PT27
Test Final Exam - Week
11 Started 2/12/22 8:16 AM
Submitted 2/12/22 9:16 AM
Due Date 2/14/22 1:59 AM
Status Completed
Attempt 96 out of 100 points
Score
Time 59 minutes out of 2 hours and 30 minutes
Elapsed
Results Feedback
Displayed
• Question 1
A 59-year-old male has been admitted to the E. D. due to a methamphetamine
overdose. The patient’s friend reported he ingested up to 2 grams because “he thought
cops were coming to get him.” The patient’s vitals are all within normal limits, except
his blood pressure is 180/110. What is the best recommendation to make at this time?
Response "When severe hypertension arises, phentolamine is recommended for
Feedback: vasodilation. Beta- or mixed alpha- and beta-adrenergic blockers (such
as propranolol or labetalol) are to be avoided because they may
exacerbate stimulant-induced cardiovascular toxicity.”
• Question 2
Disorientation, tremor, hyperactivity, fever, hallucinations, marked wakefulness, and
increased autonomic tone are all features that are consistent with which part of alcohol
withdrawal?
Response "The principal features are disorientation (to time, place, or person),
Feedback: tremor, hyperactivity, marked wakefulness, fever, increased
autonomic tone, and hallucinations.”
• Question 3
Which medication(s) requires a test dose to determine accurate use of the drug (i.e.,
how addicted the patient truly is on a certain drug) before beginning a titration schedule
to withdrawal the patient?
I. Butalbital
II. Lorazepam
III. Hydrocodone
Response
“Treatment should begin with an oral test dose of 200 mg of
Feedback: pentobarbital, a short-acting-barbiturate.”
• Question 4
, Drug addiction includes many prescription medications and illegal substances. Of the
drugs listed, which ones can be withdrawn abruptly WITHOUT medical intervention to
prevent withdraw seizures?
Response “Amphetamines can be withdrawn
Feedback: abruptly”
• Question 5
What should our treatment goal be with our patients when it comes to managing chronic
pain?
Response “In general, treatment goals are reports of pain less than 5 out of
Feedback: 10 and an improvement in function.”
• Question 6
Which of the following psychiatric conditions is present in both domains (i.e., core
psychopathology & pain-related psychological symptoms) of chronic pain that will likely
lead to an outcome of disability, pain, and poor quality of life?
Response Figure 17-4 and in the text on the page discussing how anxiety is
Feedback: present in both, therefore, a review is needed of the exact cause of
the anxiety
• Question 7
Which of the following drugs is structurally similar to tramadol; thus, its opioid-mediated
analgesia can be reversed by naloxone in mice?
Response “Structurally, venlafaxine is similar to tramadol, and in mice,
Feedback: venlafaxine demonstrates opioid-mediated analgesia that is
reversed by naloxone.”
• Question 8
Daytrana is the MPH transdermal system of methylphenidate approved for the
treatment of ADHD in children aged 6 years and older. What is the difference in terms of
the metabolism compared to the other formulations in this class?
Response referring to MPH transdermal system (MTS; Daytrana): “Since the
Feedback: MPH is absorbed through the skin, it does not undergo first-pass
metabolism by CES-1 in the liver, resulting in higher plasma MPH
levels”
• Question 9
T. C. is an 88-year-old male who is diagnosed at your clinic with Dementia with Lewy
Bodies. He currently has some debilitating gait issues, which makes his quality of life
very poor. His memory is still intact with minor deficits. Which medication would likely
benefit T. C. as his initial therapy?